Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium channel regulator activity	REM1 PACSIN3 RRAD NRXN1 NOS1	1.03e-05	54	107	5	GO:0005246
GeneOntologyMolecularFunction	extracellular matrix constituent conferring elasticity	LAMC1 FBLN2 FBN2	3.18e-05	12	107	3	GO:0030023
GeneOntologyMolecularFunction	structural molecule activity conferring elasticity	LAMC1 FBLN2 FBN2	5.22e-05	14	107	3	GO:0097493
GeneOntologyMolecularFunction	extracellular matrix structural constituent	VTN MATN2 LAMC1 FBLN2 FBN2 PXDN MMRN2	6.92e-05	188	107	7	GO:0005201
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	VLDLR LRP1 SORL1	7.96e-05	16	107	3	GO:0005041
GeneOntologyMolecularFunction	nitric-oxide synthase activity	NOS1 NOS3	8.50e-05	3	107	2	GO:0004517
GeneOntologyMolecularFunction	scaffold protein binding	PHF6 CACNA1H PLCG2 NOS1 NOS3	1.44e-04	93	107	5	GO:0097110
GeneOntologyMolecularFunction	tetrahydrobiopterin binding	NOS1 NOS3	1.69e-04	4	107	2	GO:0034617
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	VLDLR LRP1 SORL1	1.85e-04	21	107	3	GO:0030228
GeneOntologyMolecularFunction	ion channel regulator activity	REM1 PACSIN3 RRAD ANKRD36C NRXN1 NOS1	2.39e-04	162	107	6	GO:0099106
GeneOntologyMolecularFunction	channel regulator activity	REM1 PACSIN3 RRAD ANKRD36C NRXN1 NOS1	3.51e-04	174	107	6	GO:0016247
GeneOntologyMolecularFunction	transporter regulator activity	REM1 PACSIN3 RRAD ANKRD36C NRXN1 NOS1	3.84e-04	177	107	6	GO:0141108
GeneOntologyMolecularFunction	transition metal ion binding	CYLD RNF31 MYCBP2 ZNF407 LHX3 PPEF2 SKI MTPAP LIMS1 ZNF276 TRIM32 ZFHX3 RNF41 NOS1 NOS3 ALOX5	5.81e-04	1189	107	16	GO:0046914
GeneOntologyMolecularFunction	calcium ion binding	PRRG1 CACNA1E VLDLR MATN2 PPEF2 EYS FBLN2 FBN2 MEGF6 NRXN1 LRP1 NOTCH2	6.75e-04	749	107	12	GO:0005509
GeneOntologyMolecularFunction	hydroxymethyl-, formyl- and related transferase activity	SHMT1 FTCD	7.80e-04	8	107	2	GO:0016742
GeneOntologyMolecularFunction	arginine binding	NOS1 NOS3	9.99e-04	9	107	2	GO:0034618
GeneOntologyMolecularFunction	cargo receptor activity	VLDLR VTN LRP1 SORL1	1.13e-03	85	107	4	GO:0038024
GeneOntologyMolecularFunction	small GTPase binding	RIN3 MYCBP2 RABGAP1 CHML ANKRD27 RNF41 SORL1	1.72e-03	321	107	7	GO:0031267
GeneOntologyMolecularFunction	cadmium ion binding	NOS1 NOS3	1.81e-03	12	107	2	GO:0046870
GeneOntologyBiologicalProcess	axon guidance	EPHB2 EPHB6 PLXNA3 MYCBP2 MATN2 LAMC1 LHX3 NRXN1 LRP1 NOTCH2	1.97e-06	285	105	10	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	EPHB2 EPHB6 PLXNA3 MYCBP2 MATN2 LAMC1 LHX3 NRXN1 LRP1 NOTCH2	2.03e-06	286	105	10	GO:0097485
GeneOntologyBiologicalProcess	cellular catabolic process	EPHB2 NPC1 RNF31 PACSIN3 SHMT1 FTCD ECH1 SETD2 PXDN TRIM32 CLTC LRP1 RNF41 PLCG2 GPSM1 NOS1 NOS3 RUBCN SORL1	1.66e-05	1253	105	19	GO:0044248
GeneOntologyBiologicalProcess	axon development	EPHB2 EPHB6 PLXNA3 MYCBP2 USP9X MATN2 LAMC1 LHX3 NRXN1 TRIM32 LRP1 NOTCH2	1.04e-04	642	105	12	GO:0061564
GeneOntologyBiologicalProcess	negative regulation of calcium ion transport	REM1 PACSIN3 RRAD NOS1 NOS3	1.07e-04	92	105	5	GO:0051926
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	EPHB2 EPHB6 PLXNA3 VLDLR MYCBP2 USP9X MATN2 LAMC1 LHX3 ANKRD27 NRXN1 LRP1 NOTCH2	1.09e-04	748	105	13	GO:0048667
GeneOntologyBiologicalProcess	regulation of response to wounding	EPHB2 VTN MYLK LRP1 NOS3 ALOX5 GP5	1.23e-04	217	105	7	GO:1903034
GeneOntologyBiologicalProcess	response to wounding	EPHB2 VTN MYLK MATN2 CCM2L LRP1 SCNN1G PLCG2 NOS3 ALOX5 NOTCH2 GP5	1.33e-04	659	105	12	GO:0009611
GeneOntologyBiologicalProcess	axonogenesis	EPHB2 EPHB6 PLXNA3 MYCBP2 USP9X MATN2 LAMC1 LHX3 NRXN1 LRP1 NOTCH2	1.46e-04	566	105	11	GO:0007409
GeneOntologyBiologicalProcess	regulation of wound healing	EPHB2 VTN MYLK NOS3 ALOX5 GP5	2.07e-04	166	105	6	GO:0061041
GeneOntologyBiologicalProcess	wound healing	EPHB2 VTN MYLK CCM2L SCNN1G PLCG2 NOS3 ALOX5 NOTCH2 GP5	2.11e-04	493	105	10	GO:0042060
GeneOntologyBiologicalProcess	neuron projection morphogenesis	EPHB2 EPHB6 PLXNA3 VLDLR MYCBP2 USP9X MATN2 LAMC1 LHX3 ANKRD27 NRXN1 LRP1 NOTCH2	2.17e-04	802	105	13	GO:0048812
GeneOntologyBiologicalProcess	positive regulation of binding	EPHB6 VTN USP9X SKI LRP1 GPSM1	2.35e-04	170	105	6	GO:0051099
GeneOntologyBiologicalProcess	negative regulation of monoatomic ion transport	EPHB2 REM1 PACSIN3 RRAD NOS1 NOS3	2.43e-04	171	105	6	GO:0043271
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	EPHB2 EPHB6 PLXNA3 VLDLR MYCBP2 USP9X MATN2 LAMC1 LHX3 ANKRD27 NRXN1 LRP1 NOTCH2	2.66e-04	819	105	13	GO:0120039
GeneOntologyBiologicalProcess	calcium ion transport	CACNA1E REM1 MYLK PACSIN3 RRAD CACNA1H PLCG2 NOS1 NOS3 GP5	2.72e-04	509	105	10	GO:0006816
GeneOntologyBiologicalProcess	cell projection morphogenesis	EPHB2 EPHB6 PLXNA3 VLDLR MYCBP2 USP9X MATN2 LAMC1 LHX3 ANKRD27 NRXN1 LRP1 NOTCH2	2.89e-04	826	105	13	GO:0048858
GeneOntologyBiologicalProcess	positive regulation of molecular function	EPHB2 EPHB6 VLDLR VTN RNF31 USP9X SKI LIMS1 ASAP2 NRXN1 TRIM32 LRP1 RNF41 PLCG2 GPSM1 NOS1 NOS3 NOTCH2	3.04e-04	1430	105	18	GO:0044093
GeneOntologyCellularComponent	sarcolemma	REM1 RRAD CLTC CACNA1H NOS1 NOS3 ALOX5	5.24e-05	190	106	7	GO:0042383
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	VTN LAMC1 MMRN2	8.18e-05	17	106	3	GO:0098637
GeneOntologyCellularComponent	protein complex involved in cell adhesion	VTN LAMC1 NRXN1 MMRN2	2.29e-04	59	106	4	GO:0098636
GeneOntologyCellularComponent	collagen-containing extracellular matrix	VTN MATN2 LAMC1 EYS FBLN2 FBN2 PXDN MEGF6 ADAMTS17 MMRN2	3.64e-04	530	106	10	GO:0062023
GeneOntologyCellularComponent	basement membrane	VTN MATN2 LAMC1 PXDN MMRN2	3.95e-04	122	106	5	GO:0005604
GeneOntologyCellularComponent	T-tubule	REM1 RRAD CLTC NOS1	7.01e-04	79	106	4	GO:0030315
Domain	Growth_fac_rcpt_	EPHB2 EPHB6 VLDLR MATN2 LAMC1 EYS FBLN2 FBN2 MEGF6 LRP1 NOTCH2	1.23e-09	156	105	11	IPR009030
Domain	ASX_HYDROXYL	VLDLR MATN2 EYS FBLN2 FBN2 MEGF6 NRXN1 LRP1 NOTCH2	4.93e-09	100	105	9	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	VLDLR MATN2 EYS FBLN2 FBN2 MEGF6 NRXN1 LRP1 NOTCH2	8.27e-09	106	105	9	IPR000152
Domain	EGF_2	EPHB2 VLDLR MATN2 LAMC1 EYS FBLN2 FBN2 MEGF6 NRXN1 LRP1 NOTCH2 SORL1	3.14e-08	265	105	12	PS01186
Domain	EGF	VLDLR MATN2 LAMC1 EYS FBLN2 FBN2 MEGF6 NRXN1 LRP1 NOTCH2 SORL1	8.73e-08	235	105	11	SM00181
Domain	EGF-like_dom	VLDLR MATN2 LAMC1 EYS FBLN2 FBN2 MEGF6 NRXN1 LRP1 NOTCH2 SORL1	1.57e-07	249	105	11	IPR000742
Domain	EGF-like_CS	VLDLR MATN2 LAMC1 EYS FBLN2 FBN2 MEGF6 NRXN1 LRP1 NOTCH2 SORL1	2.51e-07	261	105	11	IPR013032
Domain	EGF_CA	VLDLR MATN2 EYS FBLN2 FBN2 MEGF6 LRP1 NOTCH2	4.32e-07	122	105	8	SM00179
Domain	EGF-like_Ca-bd_dom	VLDLR MATN2 EYS FBLN2 FBN2 MEGF6 LRP1 NOTCH2	4.89e-07	124	105	8	IPR001881
Domain	EGF_CA	VLDLR MATN2 FBLN2 FBN2 MEGF6 LRP1 NOTCH2	5.41e-07	86	105	7	PF07645
Domain	EGF_3	VLDLR MATN2 EYS FBLN2 FBN2 MEGF6 NRXN1 LRP1 NOTCH2 SORL1	8.34e-07	235	105	10	PS50026
Domain	EGF_Ca-bd_CS	VLDLR EYS FBLN2 FBN2 MEGF6 LRP1 NOTCH2	1.23e-06	97	105	7	IPR018097
Domain	EGF_CA	VLDLR EYS FBLN2 FBN2 MEGF6 LRP1 NOTCH2	1.41e-06	99	105	7	PS01187
Domain	EGF	VLDLR MATN2 EYS MEGF6 NRXN1 LRP1 NOTCH2	7.08e-06	126	105	7	PF00008
Domain	cEGF	MATN2 FBLN2 FBN2 LRP1	1.28e-05	26	105	4	PF12662
Domain	cEGF	MATN2 FBLN2 FBN2 LRP1	1.28e-05	26	105	4	IPR026823
Domain	EGF_1	VLDLR LAMC1 EYS FBLN2 FBN2 MEGF6 NRXN1 LRP1 NOTCH2	1.37e-05	255	105	9	PS00022
Domain	hEGF	EYS FBN2 MEGF6 NOTCH2	1.74e-05	28	105	4	PF12661
Domain	Ldl_recept_b	VLDLR LRP1 SORL1	6.01e-05	14	105	3	PF00058
Domain	LDLRB	VLDLR LRP1 SORL1	6.01e-05	14	105	3	PS51120
Domain	-	VLDLR TRIM32 LRP1 SORL1	6.67e-05	39	105	4	2.120.10.30
Domain	LY	VLDLR LRP1 SORL1	7.48e-05	15	105	3	SM00135
Domain	LDLR_classB_rpt	VLDLR LRP1 SORL1	7.48e-05	15	105	3	IPR000033
Domain	NO_synthase	NOS1 NOS3	9.36e-05	3	105	2	PF02898
Domain	NOS_euk	NOS1 NOS3	9.36e-05	3	105	2	IPR012144
Domain	-	NOS1 NOS3	9.36e-05	3	105	2	3.90.340.10
Domain	NOS_N	NOS1 NOS3	9.36e-05	3	105	2	IPR004030
Domain	NOS	NOS1 NOS3	9.36e-05	3	105	2	PS60001
Domain	6-blade_b-propeller_TolB-like	VLDLR TRIM32 LRP1 SORL1	1.28e-04	46	105	4	IPR011042
Domain	Small_GTPase_GEM/REM/Rad	REM1 RRAD	1.86e-04	4	105	2	IPR017358
Domain	FAD_binding_1	NOS1 NOS3	4.63e-04	6	105	2	PF00667
Domain	-	NOS1 NOS3	4.63e-04	6	105	2	1.20.990.10
Domain	FAD-binding_1	NOS1 NOS3	4.63e-04	6	105	2	IPR003097
Domain	NADPH_Cyt_P450_Rdtase_dom3	NOS1 NOS3	4.63e-04	6	105	2	IPR023173
Domain	-	EPHB2 EPHB6 MYCBP2 LAMC1	7.62e-04	73	105	4	2.60.120.260
Domain	Flavodoxin/NO_synth	NOS1 NOS3	8.57e-04	8	105	2	IPR008254
Domain	Flavdoxin-like	NOS1 NOS3	8.57e-04	8	105	2	IPR001094
Domain	VPS9	RIN3 ANKRD27	8.57e-04	8	105	2	SM00167
Domain	FLAVODOXIN_LIKE	NOS1 NOS3	8.57e-04	8	105	2	PS50902
Domain	Flavodoxin_1	NOS1 NOS3	8.57e-04	8	105	2	PF00258
Domain	RAS	REM1 RRAD ERAS	9.91e-04	35	105	3	PS51421
Domain	-	UTP6 INTS8 CLTC TTC22 GPSM1 CDC23	1.12e-03	207	105	6	1.25.40.10
Domain	Small_GTPase_Ras	REM1 RRAD ERAS	1.17e-03	37	105	3	IPR020849
Domain	VPS9	RIN3 ANKRD27	1.37e-03	10	105	2	PS51205
Domain	-	NOS1 NOS3	1.37e-03	10	105	2	3.40.50.360
Domain	Flavoprotein-like_dom	NOS1 NOS3	1.37e-03	10	105	2	IPR029039
Domain	Flavoprot_Pyr_Nucl_cyt_Rdtase	NOS1 NOS3	1.37e-03	10	105	2	IPR001709
Domain	VDCCAlpha1	CACNA1E CACNA1H	1.37e-03	10	105	2	IPR002077
Domain	VPS9	RIN3 ANKRD27	1.37e-03	10	105	2	PF02204
Domain	VPS9	RIN3 ANKRD27	1.37e-03	10	105	2	IPR003123
Domain	LDLR_class-A_CS	VLDLR LRP1 SORL1	1.47e-03	40	105	3	IPR023415
Domain	Ephrin_rec_like	EPHB2 EPHB6	1.67e-03	11	105	2	PF07699
Domain	Galactose-bd-like	EPHB2 EPHB6 MYCBP2 LAMC1	1.95e-03	94	105	4	IPR008979
Domain	OxRdtase_FAD/NAD-bd	NOS1 NOS3	1.99e-03	12	105	2	IPR001433
Domain	GrpE_coiled_coil	PACSIN3 TRIM32	1.99e-03	12	105	2	IPR013805
Domain	NAD_binding_1	NOS1 NOS3	1.99e-03	12	105	2	PF00175
Domain	-	HSPA4L HSPH1	1.99e-03	12	105	2	2.60.34.10
Domain	HSP70_peptide-bd	HSPA4L HSPH1	1.99e-03	12	105	2	IPR029047
Domain	TPR-like_helical_dom	UTP6 INTS8 CLTC TTC22 GPSM1 CDC23	2.04e-03	233	105	6	IPR011990
Domain	Ldl_recept_a	VLDLR LRP1 SORL1	2.06e-03	45	105	3	PF00057
Domain	-	VLDLR LRP1 SORL1	2.20e-03	46	105	3	4.10.400.10
Domain	-	HSPA4L HSPH1	2.35e-03	13	105	2	1.20.1270.10
Domain	Heat_shock_70_CS	HSPA4L HSPH1	2.35e-03	13	105	2	IPR018181
Domain	HSP70_C	HSPA4L HSPH1	2.35e-03	13	105	2	IPR029048
Domain	LDLRA_1	VLDLR LRP1 SORL1	2.49e-03	48	105	3	PS01209
Domain	LDrepeatLR_classA_rpt	VLDLR LRP1 SORL1	2.64e-03	49	105	3	IPR002172
Domain	LDLa	VLDLR LRP1 SORL1	2.64e-03	49	105	3	SM00192
Domain	LDLRA_2	VLDLR LRP1 SORL1	2.64e-03	49	105	3	PS50068
Domain	RECEPTOR_TYR_KIN_V_2	EPHB2 EPHB6	2.73e-03	14	105	2	PS00791
Domain	RECEPTOR_TYR_KIN_V_1	EPHB2 EPHB6	2.73e-03	14	105	2	PS00790
Domain	Tyr_kinase_rcpt_V_CS	EPHB2 EPHB6	2.73e-03	14	105	2	IPR001426
Domain	EphA2_TM	EPHB2 EPHB6	2.73e-03	14	105	2	PF14575
Domain	Ephrin_rcpt_lig-bd_dom	EPHB2 EPHB6	2.73e-03	14	105	2	IPR001090
Domain	Eph_TM	EPHB2 EPHB6	2.73e-03	14	105	2	IPR027936
Domain	EPH_lbd	EPHB2 EPHB6	2.73e-03	14	105	2	SM00615
Domain	Ephrin_lbd	EPHB2 EPHB6	2.73e-03	14	105	2	PF01404
Domain	Tyr_kinase_ephrin_rcpt	EPHB2 EPHB6	2.73e-03	14	105	2	IPR016257
Domain	EPH_LBD	EPHB2 EPHB6	2.73e-03	14	105	2	PS51550
Domain	EMI_domain	MEGF6 MMRN2	3.57e-03	16	105	2	IPR011489
Domain	HSP70	HSPA4L HSPH1	3.57e-03	16	105	2	PF00012
Domain	HSP70_2	HSPA4L HSPH1	4.03e-03	17	105	2	PS00329
Domain	EMI	MEGF6 MMRN2	4.03e-03	17	105	2	PS51041
Domain	DUF1605	DHX40 DHX8	4.03e-03	17	105	2	IPR011709
Domain	HSP70_1	HSPA4L HSPH1	4.03e-03	17	105	2	PS00297
Domain	HSP70_3	HSPA4L HSPH1	4.03e-03	17	105	2	PS01036
Domain	OB_NTP_bind	DHX40 DHX8	4.03e-03	17	105	2	PF07717
Domain	HA2	DHX40 DHX8	4.52e-03	18	105	2	SM00847
Domain	HA2	DHX40 DHX8	4.52e-03	18	105	2	PF04408
Domain	Helicase-assoc_dom	DHX40 DHX8	4.52e-03	18	105	2	IPR007502
Domain	Hsp_70_fam	HSPA4L HSPH1	4.52e-03	18	105	2	IPR013126
Domain	Fd_Rdtase_FAD-bd	NOS1 NOS3	5.03e-03	19	105	2	IPR017927
Domain	FAD_FR	NOS1 NOS3	5.03e-03	19	105	2	PS51384
Domain	Riboflavin_synthase-like_b-brl	NOS1 NOS3	5.03e-03	19	105	2	IPR017938
Domain	RCC1	MYCBP2 NEK9	5.57e-03	20	105	2	PF00415
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MORN1 MYCBP2 MBNL1 PHF6 RABGAP1 SKI ECH1 INTS8 NEK9 ASAP2 PXDN DPP9 MEGF6 MBNL2 LRP1 RBM5 ZFHX3 CACNA1H NOTCH2	1.34e-07	1489	107	19	28611215
Pubmed	Human transcription factor protein interaction networks.	CYLD SIN3B HSPA4L DIS3L USP9X DHX40 HSPH1 MBNL1 PHF6 LHX3 SKI ECH1 FBN2 ZFHX3 USP54 VDAC2 PPP6R3 SORL1	3.61e-07	1429	107	18	35140242
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	EPHB2 FOXM1 SIN3B SPOUT1 USP9X HSPH1 MBNL1 CPOX ATAD2 CCNT2 SETD2 LIMS1 CLTC RBM5 CHCHD1 VDAC2 PPP6R3	6.30e-07	1327	107	17	32694731
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	UTP6 RNF31 SPOUT1 MYCBP2 DHX40 HSPH1 PHF6 ECH1 ATAD2 NEK9 MTPAP ANKRD27 TRIM32 CLTC PLCG2 NUP160 VDAC2	8.22e-07	1353	107	17	29467282
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	EPHB2 NPC1 PLXNA3 MYCBP2 HSPA4L MATN2 HSPH1 LAMC1 RABGAP1 NEK9 FBN2 PXDN LRP1 NOTCH2 PPP6R3 SORL1	8.39e-07	1201	107	16	35696571
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	VTN MATN2 LAMC1 FBLN2 PXDN ADAMTS17 MMRN2	9.04e-07	167	107	7	22159717
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	VTN MATN2 LAMC1 FBLN2 FBN2 PXDN MEGF6	1.24e-06	175	107	7	28071719
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CYLD VLDLR RNF31 DIS3L BACH2 SKI MTPAP SETD2 FBN2 LRP1 ZFHX3 USP54 NOTCH2 CDC23 SORL1	1.72e-06	1116	107	15	31753913
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	FOXM1 CYLD USP9X DHX40 BACH2 RABGAP1 SETD2 CLTC CDC23 PPP6R3 SORL1	2.10e-06	588	107	11	38580884
Pubmed	HIV-1 protein Tat produces biphasic changes in NMDA-evoked increases in intracellular Ca2+ concentration via activation of Src kinase and nitric oxide signaling pathways.	LRP1 NOS1 NOS3	2.35e-06	9	107	3	24666322
Pubmed	Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.	VLDLR LRP1 SORL1	2.35e-06	9	107	3	20005821
Pubmed	PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor.	EPHB2 EPHB6 NRXN1	2.35e-06	9	107	3	9707552
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYCBP2 LAMC1 ZNF407 RRAD NEK9 LIMS1 TRIM32 CLTC RBM5 NOTCH2	3.31e-06	497	107	10	23414517
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	MYCBP2 HSPA4L USP9X SETD2 CLTC USP54 NUP160 CDC23 PPP6R3	9.19e-06	440	107	9	34244565
Pubmed	Deletion of the Gamma Subunit of ENaC in Endothelial Cells Does Not Protect against Renal Ischemia Reperfusion Injury.	SCNN1G NOS3	9.38e-06	2	107	2	34681576
Pubmed	Differential roles of neuronal and endothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia.	NOS1 NOS3	9.38e-06	2	107	2	15350652
Pubmed	Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling.	NOS1 NOS3	9.38e-06	2	107	2	24643800
Pubmed	Compound loss of muscleblind-like function in myotonic dystrophy.	MBNL1 MBNL2	9.38e-06	2	107	2	24293317
Pubmed	Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with the development of lupus nephritis.	NOS1 NOS3	9.38e-06	2	107	2	15119548
Pubmed	Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS.	NOS1 NOS3	9.38e-06	2	107	2	21825026
Pubmed	Chronic NOS inhibition actuates endothelial-mesenchymal transformation.	NOS1 NOS3	9.38e-06	2	107	2	16963618
Pubmed	Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice.	NOS1 NOS3	9.38e-06	2	107	2	8667023
Pubmed	nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle.	NOS1 NOS3	9.38e-06	2	107	2	11015578
Pubmed	Renal cortical and medullary blood flow responses to L-NAME and ANG II in wild-type, nNOS null mutant, and eNOS null mutant mice.	NOS1 NOS3	9.38e-06	2	107	2	15961532
Pubmed	Optical Mapping Approaches on Muscleblind-Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy.	MBNL1 MBNL2	9.38e-06	2	107	2	28416514
Pubmed	Contributions of endothelial and neuronal nitric oxide synthases to cerebrovascular responses to hyperoxia.	NOS1 NOS3	9.38e-06	2	107	2	14526232
Pubmed	Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.	MBNL1 MBNL2	9.38e-06	2	107	2	31754023
Pubmed	Altered levels of the splicing factor muscleblind modifies cerebral cortical function in mouse models of myotonic dystrophy.	MBNL1 MBNL2	9.38e-06	2	107	2	29331264
Pubmed	Mbnl1 and Mbnl2 regulate brain structural integrity in mice.	MBNL1 MBNL2	9.38e-06	2	107	2	34848815
Pubmed	Nitric oxide synthase polymorphisms and asthma phenotypes in Chinese children.	NOS1 NOS3	9.38e-06	2	107	2	16238787
Pubmed	Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.	NOS1 NOS3	9.38e-06	2	107	2	24076963
Pubmed	Normal development of the ipsilateral retinocollicular pathway and its disruption in double endothelial and neuronal nitric oxide synthase gene knockout mice.	NOS1 NOS3	9.38e-06	2	107	2	11027405
Pubmed	Neuronal nitric oxide synthase plays a key role in CNS demyelination.	NOS1 NOS3	9.38e-06	2	107	2	17151270
Pubmed	Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism.	NOS1 NOS3	9.38e-06	2	107	2	18305236
Pubmed	High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma.	FOXM1 FAM83A	9.38e-06	2	107	2	37904848
Pubmed	Regulation of renin gene expression in kidneys of eNOS- and nNOS-deficient mice.	NOS1 NOS3	9.38e-06	2	107	2	10764216
Pubmed	Repetitive hyperbaric oxygen exposures enhance sensitivity to convulsion by upregulation of eNOS and nNOS.	NOS1 NOS3	9.38e-06	2	107	2	18342297
Pubmed	Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity.	NOS1 NOS3	9.38e-06	2	107	2	7488039
Pubmed	The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration.	NOS1 NOS3	9.38e-06	2	107	2	19087148
Pubmed	Genetic analysis of NOS isoforms using nNOS and eNOS knockout animals.	NOS1 NOS3	9.38e-06	2	107	2	9932431
Pubmed	Rapid cerebral ischemic preconditioning in mice deficient in endothelial and neuronal nitric oxide synthases.	NOS1 NOS3	9.38e-06	2	107	2	12677017
Pubmed	Experience-dependent plasticity acts via GluR1 and a novel neuronal nitric oxide synthase-dependent synaptic mechanism in adult cortex.	NOS1 NOS3	9.38e-06	2	107	2	21813683
Pubmed	Gender specific hippocampal whole genome transcriptome data from mice lacking the Cav2.3 R-type or Cav3.2 T-type voltage-gated calcium channel.	CACNA1E CACNA1H	9.38e-06	2	107	2	28393090
Pubmed	Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotriene production.	NOS1 NOS3	9.38e-06	2	107	2	15044250
Pubmed	Cutaneous neuronal nitric oxide is specifically decreased in postural tachycardia syndrome.	NOS1 NOS3	9.38e-06	2	107	2	17660395
Pubmed	Endothelial Nitric Oxide Synthase Is Present in Dendritic Spines of Neurons in Primary Cultures.	NOS1 NOS3	9.38e-06	2	107	2	28725180
Pubmed	Reproductive function in female mice lacking the gene for endothelial nitric oxide synthase.	NOS1 NOS3	9.38e-06	2	107	2	10534440
Pubmed	Analysis of nitric oxide synthase gene polymorphisms in neonatal respiratory distress syndrome among the Chinese Han population.	NOS1 NOS3	9.38e-06	2	107	2	24602444
Pubmed	Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice.	NOS1 NOS3	9.38e-06	2	107	2	12788381
Pubmed	Angiotensin II response in afferent arterioles of mice lacking either the endothelial or neuronal isoform of nitric oxide synthase.	NOS1 NOS3	9.38e-06	2	107	2	17959704
Pubmed	Effects of nitric oxide synthase gene knockout on neurotransmitter release in vivo.	NOS1 NOS3	9.38e-06	2	107	2	9692709
Pubmed	Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: relationship to clinical status.	NOS1 NOS3	9.38e-06	2	107	2	23770231
Pubmed	Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.	NOS1 NOS3	9.38e-06	2	107	2	15287858
Pubmed	Mice with gene disruption of both endothelial and neuronal nitric oxide synthase exhibit insulin resistance.	NOS1 NOS3	9.38e-06	2	107	2	10905473
Pubmed	Nitric oxide synthase gene polymorphisms in children with minimal change nephrotic syndrome.	NOS1 NOS3	9.38e-06	2	107	2	19371282
Pubmed	Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms.	NOS1 NOS3	9.38e-06	2	107	2	11907582
Pubmed	Relative contribution of eNOS and nNOS to endothelium-dependent vasodilation in the mouse aorta.	NOS1 NOS3	9.38e-06	2	107	2	20624383
Pubmed	Neuronal NOS-cGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice.	NOS1 NOS3	9.38e-06	2	107	2	9486242
Pubmed	Refinement of the ipsilateral retinocollicular projection is disrupted in double endothelial and neuronal nitric oxide synthase gene knockout mice.	NOS1 NOS3	9.38e-06	2	107	2	10727738
Pubmed	Developmental changes in the response of murine cerebellar granule cells to nitric oxide.	NOS1 NOS3	9.38e-06	2	107	2	18406496
Pubmed	Diminished NO generation by injured endothelium and loss of macula densa nNOS may contribute to sustained acute kidney injury after ischemia-reperfusion.	NOS1 NOS3	9.38e-06	2	107	2	18971208
Pubmed	Does endothelial nitric oxide synthase gene variation play a role in the occurrence of hypertension in pregnancy?	NOS1 NOS3	9.38e-06	2	107	2	12908999
Pubmed	Role of nitric oxide synthase on brain GABA transaminase activity and GABA levels.	NOS1 NOS3	9.38e-06	2	107	2	31259693
Pubmed	Voltage-dependent anion channel-2 interaction with nitric oxide synthase enhances pulmonary artery endothelial cell nitric oxide production.	NOS3 VDAC2	9.38e-06	2	107	2	22842492
Pubmed	Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles.	NOS1 NOS3	9.38e-06	2	107	2	11161004
Pubmed	Neuronal and endothelial nitric oxide synthase gene knockout mice.	NOS1 NOS3	9.38e-06	2	107	2	10559836
Pubmed	The cerebral metabolic consequences of nitric oxide synthase deficiency: glucose utilization in endothelial and neuronal nitric oxide synthase null mice.	NOS1 NOS3	9.38e-06	2	107	2	10027769
Pubmed	Priapism in a Fabry disease mouse model is associated with upregulated penile nNOS and eNOS expression.	NOS1 NOS3	9.38e-06	2	107	2	29110178
Pubmed	Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility.	NOS1 NOS3	9.38e-06	2	107	2	32956449
Pubmed	Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.	MBNL1 MBNL2	9.38e-06	2	107	2	22901804
Pubmed	Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection.	NOS1 NOS3	9.38e-06	2	107	2	11904450
Pubmed	Modulation by NO of acetylcholine release in the ileum of wild-type and NOS gene knockout mice.	NOS1 NOS3	9.38e-06	2	107	2	12381527
Pubmed	Contribution of nNOS- and eNOS-derived NO to microvascular smooth muscle NO exposure.	NOS1 NOS3	9.38e-06	2	107	2	15033959
Pubmed	Ubiquitin ligase and signalling hub MYCBP2 is required for efficient EPHB2 tyrosine kinase receptor function.	EPHB2 MYCBP2	9.38e-06	2	107	2	38289221
Pubmed	Infarct size and nitric oxide synthase in murine myocardium.	NOS1 NOS3	9.38e-06	2	107	2	10652188
Pubmed	Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.	MBNL1 MBNL2	9.38e-06	2	107	2	20009516
Pubmed	Gastric stasis in neuronal nitric oxide synthase-deficient knockout mice.	NOS1 NOS3	9.38e-06	2	107	2	10982771
Pubmed	Distal Alternative Last Exons Localize mRNAs to Neural Projections.	MBNL1 MBNL2	9.38e-06	2	107	2	26907613
Pubmed	Regulation of brain glutamate metabolism by nitric oxide and S-nitrosylation.	NOS1 NOS3	9.38e-06	2	107	2	26152695
Pubmed	Alternatively spliced neuronal nitric oxide synthase mediates penile erection.	NOS1 NOS3	9.38e-06	2	107	2	16488973
Pubmed	The Krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach.	NOS1 NOS3	9.38e-06	2	107	2	19095954
Pubmed	Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo.	NOS1 NOS3	9.38e-06	2	107	2	18048451
Pubmed	Non-Mendelian inheritance during inbreeding of Cav3.2 and Cav2.3 deficient mice.	CACNA1E CACNA1H	9.38e-06	2	107	2	33009476
Pubmed	MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.	MBNL1 MBNL2	9.38e-06	2	107	2	26257173
Pubmed	Immunocytochemical distribution of nitric oxide synthase in the human seminal vesicle: a light and electron microscopical study.	NOS1 NOS3	9.38e-06	2	107	2	12802542
Pubmed	Oxygen seizure latency and peroxynitrite formation in mice lacking neuronal or endothelial nitric oxide synthases.	NOS1 NOS3	9.38e-06	2	107	2	12781920
Pubmed	Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS.	NOS1 NOS3	9.38e-06	2	107	2	7518615
Pubmed	Proteolytic degradation of nitric oxide synthase isoforms by calpain is modulated by the expression levels of HSP90.	NOS1 NOS3	9.38e-06	2	107	2	17970747
Pubmed	Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms.	NOS1 NOS3	9.38e-06	2	107	2	17351927
Pubmed	Opposing roles of miR-294 and MBNL1/2 in shaping the gene regulatory network of embryonic stem cells.	MBNL1 MBNL2	9.38e-06	2	107	2	29735517
Pubmed	Establishment of patterned thalamocortical connections does not require nitric oxide synthase.	NOS1 NOS3	9.38e-06	2	107	2	9786989
Pubmed	Two separate Ni(2+) -sensitive voltage-gated Ca(2+) channels modulate transretinal signalling in the isolated murine retina.	CACNA1E CACNA1H	9.38e-06	2	107	2	21883984
Pubmed	Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release.	NOS1 NOS3	9.38e-06	2	107	2	18046021
Pubmed	Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.	MBNL1 MBNL2	9.38e-06	2	107	2	20098426
Pubmed	Nitric oxide synthase gene polymorphisms in children with primary nocturnal enuresis: a preliminary study.	NOS1 NOS3	9.38e-06	2	107	2	17365914
Pubmed	NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits.	NOS1 NOS3	9.38e-06	2	107	2	17579350
Pubmed	Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation.	NOS1 NOS3	9.38e-06	2	107	2	16545353
Pubmed	A mechanoresponsive PINCH-1-Notch2 interaction regulates smooth muscle differentiation of human placental mesenchymal stem cells.	LIMS1 NOTCH2	9.38e-06	2	107	2	33529444
Pubmed	Neuronal nitric oxide synthase in epidermis is involved in cutaneous circulatory response to mechanical stimulation.	NOS1 NOS3	9.38e-06	2	107	2	19940861
Pubmed	Displacement-encoded and manganese-enhanced cardiac MRI reveal that nNOS, not eNOS, plays a dominant role in modulating contraction and calcium influx in the mammalian heart.	NOS1 NOS3	9.38e-06	2	107	2	22058155
Interaction	IGFL3 interactions	VLDLR MYCBP2 FBN2 PXDN NOTCH2 SORL1	2.91e-06	75	107	6	int:IGFL3
Interaction	FOXD4L6 interactions	RNF31 FBN2 NOTCH2 PPP6R3 SORL1	6.08e-06	49	107	5	int:FOXD4L6
Interaction	ZNF408 interactions	VLDLR USP9X FBLN2 FBN2 NOTCH2 CDC23 SORL1	1.23e-05	145	107	7	int:ZNF408
Interaction	ANKRD36B interactions	VLDLR ANKRD36C LRP1 GAN SORL1	1.66e-05	60	107	5	int:ANKRD36B
Interaction	DUSP10 interactions	HSPA4L FBN2 LRP1 PPP6R3 SORL1	3.78e-05	71	107	5	int:DUSP10
GeneFamily	RGK type GTPase family	REM1 RRAD	1.21e-04	4	82	2	1260
GeneFamily	VPS9 domain containing	RIN3 ANKRD27	8.93e-04	10	82	2	928
GeneFamily	Low density lipoprotein receptors	VLDLR LRP1	1.53e-03	13	82	2	634
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHB2 EPHB6	1.78e-03	14	82	2	1095
GeneFamily	Ubiquitin specific peptidases	CYLD USP9X USP54	2.10e-03	56	82	3	366
GeneFamily	DEAH-box helicases	DHX40 DHX8	2.34e-03	16	82	2	500
GeneFamily	Heat shock 70kDa proteins	HSPA4L HSPH1	2.64e-03	17	82	2	583
GeneFamily	Bardet-Biedl syndrome associated\|BBSome	BBS9 TRIM32	4.03e-03	21	82	2	980
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	RNF31 RBM5	4.03e-03	21	82	2	89
GeneFamily	Ankyrin repeat domain containing	ANKRD30B ANKRD36C ANKRD27 ASAP2 NOTCH2	4.87e-03	242	82	5	403
GeneFamily	Fibronectin type III domain containing	EPHB2 EPHB6 MYLK SORL1	6.05e-03	160	82	4	555
GeneFamily	Calcium voltage-gated channel subunits	CACNA1E CACNA1H	6.15e-03	26	82	2	253
Coexpression	NABA_ECM_GLYCOPROTEINS	VTN MATN2 LAMC1 EYS FBLN2 FBN2 PXDN MMRN2	1.47e-06	196	107	8	M3008
Coexpression	NABA_ECM_GLYCOPROTEINS	VTN MATN2 LAMC1 FBLN2 FBN2 PXDN MMRN2	1.38e-05	191	107	7	MM17059
Coexpression	NABA_CORE_MATRISOME	VTN MATN2 LAMC1 EYS FBLN2 FBN2 PXDN MMRN2	1.76e-05	275	107	8	M5884
Coexpression	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	MYLK MATN2 LAMC1 FBLN2 FBN2 LRP1 NOTCH2	1.86e-05	200	107	7	M5930
Coexpression	GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP	MYCBP2 DHX40 NEK9 CCNT2 CLTC NOTCH2 SORL1	1.86e-05	200	107	7	M9041
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	NPC1 RIN3 MBNL1 LAMC1 RABGAP1 ECH1 ATAD2 MBNL2 TRIM32 CLTC NOTCH2 FAM83A VDAC2	4.01e-05	843	107	13	M2356
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK DHRS11 LAMC1 LRP1 ZFHX3 CACNA1H RUBCN	1.62e-08	185	107	8	38486b69c48dc5e1c4e1488208fa8954a973eccb
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN MYLK DHRS11 LAMC1 LRP1 ZFHX3 CACNA1H RUBCN	1.62e-08	185	107	8	3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	APCDD1 BACH2 LAMC1 FBLN2 PXDN LRP1 ZFHX3	3.52e-07	187	107	7	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	REM1 MATN2 RRAD LIMS1 NRXN1 ZFHX3 NOTCH2	3.91e-07	190	107	7	106862ef44fcaa0971c3ba0147d13eb08015ca77
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RABGAP1 ASAP2 FBLN2 CCM2L MEGF6 MMRN2 NOS3	3.91e-07	190	107	7	d87b9e9ca863270a9c7f61674271a6440c97d1f4
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A VTN REM1 MYLK PACSIN3 RRAD CACNA1H	3.91e-07	190	107	7	1ab3f19f1ce9f58e5125135704d94655a2e330a0
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RABGAP1 ASAP2 FBLN2 CCM2L MEGF6 MMRN2 NOS3	4.20e-07	192	107	7	285a9d332a1e07b94f222d4b518dd56928b9e075
ToppCell	LA\|World / Chamber and Cluster_Paper	CACNA1E BACH2 LAMC1 FBLN2 PXDN LRP1 ZFHX3	4.35e-07	193	107	7	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	BACH2 LAMC1 ASAP2 FBLN2 PXDN LRP1 ZFHX3	4.66e-07	195	107	7	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A CCM2L ERAS MMRN2 NOS1 NOS3	2.22e-06	157	107	6	275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TRAPPC11 MATN2 CCNT2 RNF41 USP54 NOS1	3.63e-06	171	107	6	6a2f88c2a62cb2f69797804e24eb1137a3e148de
ToppCell	356C-Endothelial_cells-Endothelial-B_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	TRAPPC11 MATN2 CCNT2 RNF41 USP54 NOS1	3.63e-06	171	107	6	9be3554626408bb897d1f1c43b3ab4a92651f2e2
ToppCell	facs-Heart-RV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN REM1 MYLK PACSIN3 NRXN1 SORL1	5.53e-06	184	107	6	9c20b50f8d6ac689d41d5440c835f9db8d04758b
ToppCell	facs-Heart-RV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN REM1 MYLK PACSIN3 NRXN1 SORL1	5.53e-06	184	107	6	31dbe6119a3bcd266ae5e9b340c853d9ff680dce
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EPHB2 PDE3A MATN2 FBLN2 FBN2 ZFHX3	5.71e-06	185	107	6	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PDE3A ASAP2 FBLN2 MMRN2 PLCG2 NOS3	6.07e-06	187	107	6	66ebe1788d51b3e17bec6cdb219f709756b4e530
ToppCell	P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PDE3A FBLN2 MEGF6 MMRN2 NOS3 GP5	6.26e-06	188	107	6	50b27fc12347ca16bd62333baf345c83cb422a8f
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	PDE3A CCM2L MMRN2 PLCG2 NOS1 NOS3	6.45e-06	189	107	6	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	facs-Heart-RA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN REM1 MYLK LIMS1 MEGF6 NRXN1	6.65e-06	190	107	6	bfbdf16d488359d7935a419c4c1823288f39c183
ToppCell	facs-Heart-RA-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN REM1 MYLK LIMS1 MEGF6 NRXN1	6.65e-06	190	107	6	eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-Cd34+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR REM1 MATN2 LAMC1 FBLN2 LRP1	6.85e-06	191	107	6	6cab0334f76c973880bd8d1638856f2f6e4a249a
ToppCell	droplet-Fat-Gat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR REM1 MATN2 LAMC1 FBLN2 LRP1	6.85e-06	191	107	6	850c6fff6dc795431ef534fdaa41e4ad50f7367a
ToppCell	droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR REM1 MATN2 LAMC1 FBLN2 LRP1	6.85e-06	191	107	6	8b2b00202d3c98bccbae1b4a23713892fad0ff23
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	VLDLR REM1 MYLK LIMS1 ADAMTS17 LRP1	6.85e-06	191	107	6	e7c605b56934d1383237c1f946dbccef25d91368
ToppCell	P03-Endothelial-large_vessel_endothelial_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PDE3A ASAP2 FBLN2 MEGF6 MMRN2 NOS3	6.85e-06	191	107	6	b680e0c35f1004be36f9f0680ae3c62952e2b607
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A VTN MYLK RRAD ZFHX3 NOTCH2	6.85e-06	191	107	6	96ff4cfbdcaec4b8568f9482d732dddd399121d3
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VLDLR REM1 MYLK LAMC1 ADAMTS17 LRP1	7.06e-06	192	107	6	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VLDLR REM1 MYLK ECH1 ADAMTS17 LRP1	7.06e-06	192	107	6	2802fae55683345ff94a1ecf73b6fbee4f17481e
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN REM1 MYLK PACSIN3 RRAD CACNA1H	7.06e-06	192	107	6	88472b99970ba0decbf87164fc241a1c77b3b389
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VLDLR REM1 MYLK LAMC1 ADAMTS17 LRP1	7.06e-06	192	107	6	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VLDLR REM1 MYLK ECH1 ADAMTS17 LRP1	7.06e-06	192	107	6	e79f2253e084a9ab9afcaf7ec42a5012ade42d36
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN REM1 MYLK PACSIN3 RRAD CACNA1H	7.27e-06	193	107	6	b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ASAP2 FBLN2 CCM2L MEGF6 MMRN2 NOS3	7.27e-06	193	107	6	58c590dd6f21bc7ae58ae1729dd574c0f1069592
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR REM1 MATN2 LAMC1 FBLN2 LRP1	7.49e-06	194	107	6	da926441053b499cb5107ccb116fb1b3844d82b7
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR REM1 MATN2 LAMC1 FBLN2 LRP1	7.49e-06	194	107	6	54a7f693966b5c02f6b248950ddb5fa32af3ae67
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A VTN MYLK RRAD ZFHX3 NOTCH2	7.49e-06	194	107	6	3bff2e4eb16719ab7419b2f94c9c6e7302aa6629
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR REM1 MATN2 LAMC1 FBLN2 LRP1	7.49e-06	194	107	6	f34b3bbdebf56f66ff499e390e5515a4a4093f90
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	BACH2 LAMC1 ASAP2 FBLN2 LRP1 ZFHX3	7.49e-06	194	107	6	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A VTN MYLK RRAD ZFHX3 NOTCH2	7.49e-06	194	107	6	fdaf61cbe7f77ff5358d150b38adb1fe3778e961
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VLDLR REM1 MYLK LAMC1 ADAMTS17 LRP1	7.71e-06	195	107	6	3a0cad69cfc150a27a0666f612f5294c817197d7
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	APCDD1 LAMC1 FBLN2 PXDN LRP1 NOTCH2	7.71e-06	195	107	6	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VLDLR REM1 MYLK LAMC1 ADAMTS17 LRP1	7.71e-06	195	107	6	2b8ee7990267bb52b7e6ae03f509ffebf8908122
ToppCell	droplet-Limb_Muscle-MUSCLE-1m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 LAMC1 SKI FBN2 PXDN MBNL2	7.71e-06	195	107	6	fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2
ToppCell	P03-Mesenchymal\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VLDLR REM1 MYLK ECH1 ADAMTS17 LRP1	7.71e-06	195	107	6	6180309c6ae278b996fd98c57461cbc129c028ba
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	APCDD1 MATN2 FBLN2 CCM2L MMRN2 NOS3	7.94e-06	196	107	6	a20a56d8997d6db2a10046c8801c619a379de83c
ToppCell	severe-unassigned\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FOXM1 CACNA1E MYLK DIS3L ATAD2 PLCG2	8.17e-06	197	107	6	70704b149b2820b8601d2495b7cd9cbe91eda262
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	PDE3A MYLK BACH2 LAMC1 FBLN2 GPSM1	8.41e-06	198	107	6	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A FBLN2 CCM2L MMRN2 NOS1 NOS3	8.41e-06	198	107	6	002424b24dacac553e02d0f764a6e8a1e567b9df
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	CACNA1E PDE3A REM1 MYLK RRAD NOS3	8.66e-06	199	107	6	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	TRAPPC11 USP9X BACH2 LIMS1 PXDN NOTCH2	8.66e-06	199	107	6	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Parenchyma_COVID-19-Stromal-TX-Smooth_muscle-1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	PDE3A REM1 MYLK RRAD PXDN CACNA1H	8.91e-06	200	107	6	78e9a40153d7ba5d9ea6393a37d26fc5c0220867
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PDE3A REM1 MYLK RRAD PXDN CACNA1H	8.91e-06	200	107	6	c46e06b4f22d3456e67bc62a9ac198e8041965ad
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE3A REM1 MYLK RRAD PXDN CACNA1H	8.91e-06	200	107	6	43b76e382b38b9856c07557a75e5b1ce0cee1d9e
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	APCDD1 MATN2 LAMC1 FBLN2 ADAMTS17 LRP1	8.91e-06	200	107	6	efdf7066b7dd43e35dbc0d2719b75f250cf54af2
ToppCell	Frontal_cortex-Endothelial-MURAL-M1(Rgs5Acta2)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	PDE3A VTN REM1 MYLK RRAD	3.22e-05	151	107	5	527059e47e381b2f6d63c1abb39bc0795ee3829d
ToppCell	Frontal_cortex-Endothelial-MURAL\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	PDE3A VTN REM1 MYLK RRAD	3.22e-05	151	107	5	7570372a315bc312ff57bb5f483375c401ae8787
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	VLDLR REM1 LIMS1 MBNL2 ADAMTS17	4.37e-05	161	107	5	b19f82dd98a3064581793711bb70373f18abecd9
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	ECH1 ANKRD27 GAN NOTCH2 SORL1	4.50e-05	162	107	5	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FBLN2 CCM2L MMRN2 NOS1 NOS3	4.50e-05	162	107	5	25bb1b9709f960fdf90faff56e874f52a8f5d17e
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	PDE3A REM1 RNF31 BACH2 FBN2	4.91e-05	165	107	5	3d2acdae0dd2b79a15f74158e8e566ce22b4218e
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RABGAP1 FBLN2 CCM2L MMRN2 NOS3	5.05e-05	166	107	5	7a45785a40b7425f97be67bab1c5ceb69b2bd85a
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RABGAP1 FBLN2 CCM2L MMRN2 NOS3	5.05e-05	166	107	5	bbd382812f8a84a5d99888de2d7cca3a8b5e4695
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RRAD ATAD2 LIMS1 NRXN1 GPSM1	5.20e-05	167	107	5	b0eb7a40491dd2432f5282f578ce569df86d21a7
ToppCell	Posterior_cortex-Endothelial-MURAL\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PDE3A VTN REM1 MYLK RRAD	5.50e-05	169	107	5	0ae65daf092396b71f790b65c7a2feed90397417
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PDE3A VTN REM1 MYLK RRAD	5.50e-05	169	107	5	8cd70ce27b1cecb83f8a376230e7ef41b079b124
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PDE3A REM1 APCDD1 BACH2 DBR1	5.81e-05	171	107	5	e59afa0a773dca3b9c208d17510ea55703b42598
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	CYLD HSPH1 MBNL1 ZNF407 ANKRD36C	5.81e-05	171	107	5	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A CCM2L PLCG2 NOS1 NOS3	5.81e-05	171	107	5	1597459c971d6befa991d59dc66b41b6a522f797
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega\|lymph-node_spleen / Manually curated celltypes from each tissue	PDE3A MYLK ASAP2 PKLR FAM83A	6.49e-05	175	107	5	5ca3369ce2c2bb88ba097260195aecd67cec1a3a
ToppCell	wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PDE3A FBLN2 FBN2 MMRN2 NOS1	6.66e-05	176	107	5	52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXNA3 NUGGC SHMT1 BBS9 CACNA1H	6.84e-05	177	107	5	c6812679aa6522d03bd29144e71c5fae6a92325e
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-Plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXNA3 NUGGC SHMT1 BBS9 CACNA1H	6.84e-05	177	107	5	ff97398d2adb83063b7c53a264bfae86ea7ea304
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EYS CCM2L MMRN2 PLCG2 NOS1	7.03e-05	178	107	5	c227da59dc7beb73f84405bf13356bdeb59d9338
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A FBLN2 MEGF6 MMRN2 NOS3	7.22e-05	179	107	5	a09647750eba9d93c5efc1db3b555fefb5eec7b5
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HSPH1 ANKRD36C PLCG2 USP54 SORL1	7.22e-05	179	107	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PDE3A FBLN2 FBN2 MMRN2 NOS1	7.22e-05	179	107	5	8c9ed247e1c4d655b81ce2f24a9936a7cade718a
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	VTN MYLK RRAD LIMS1 NRXN1	7.22e-05	179	107	5	56db12467b445f2b8ef92af50779eeab10413eb2
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATAD2 FBLN2 FBN2 MMRN2 NUP160	7.41e-05	180	107	5	baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c
ToppCell	AT1-AT2_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	EPHB2 BACH2 FBN2 PXDN CACNA1H	7.41e-05	180	107	5	3c7b2033821f9e34e2924bd8655f566edcbcc7d3
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATAD2 FBLN2 FBN2 MMRN2 NUP160	7.41e-05	180	107	5	2d608b9394d28d19cfc85c6ac94003d5177c8a92
ToppCell	facs-Lung-24m-Endothelial-arterial_endothelial\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATAD2 FBLN2 FBN2 MMRN2 NUP160	7.41e-05	180	107	5	0f9b27054358c4737eed06c8ea01987cccc3cb55
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	VLDLR REM1 MYLK ADAMTS17 LRP1	7.81e-05	182	107	5	ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCell	Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PDE3A VTN REM1 MYLK RRAD	7.81e-05	182	107	5	da61e7cb2537c567968d8bd8baf537ecdff0ab18
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A PLSCR5 PXDN ADAMTS17 NOTCH2	7.81e-05	182	107	5	d3a037268f026eb2f84428b1821022503cef7756
ToppCell	Cerebellum-Endothelial-MURAL\|Cerebellum / BrainAtlas - Mouse McCarroll V32	PDE3A VTN REM1 MYLK RRAD	7.81e-05	182	107	5	b2f03f61aebb5920595fed8b9d6799a09353419b
ToppCell	facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A RABGAP1 FBLN2 MMRN2 NOS3	8.01e-05	183	107	5	12e876d6205af8aad74265c668b5e95b9e7487f3
ToppCell	Basal\|World / shred by cell class for mouse tongue	MATN2 SHMT1 ASAP2 MEGF6 ZFHX3	8.01e-05	183	107	5	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN REM1 MYLK PACSIN3 NRXN1	8.01e-05	183	107	5	0f02136359787bd78146617990968baa47a65d86
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VTN REM1 MYLK PACSIN3 NRXN1	8.01e-05	183	107	5	2f0dcc65ad4d90ef946919b4462280fdd20c5ea0
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBLN2 CCM2L MEGF6 MMRN2 NOS3	8.01e-05	183	107	5	fc9a7ba148c22d0c8a46f6bc56c772929ac496f7
ToppCell	nucseq-Immune-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NUGGC MYCBP2 BACH2 PLCG2 RUBCN	8.22e-05	184	107	5	911658e7bb499c1bbc8419eec8ff88729bc39a75
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A VTN MYLK RRAD ZFHX3	8.22e-05	184	107	5	89ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EYS CCM2L MMRN2 PLCG2 NOS1	8.22e-05	184	107	5	a809b0fa52df8a159f60f87eefcef61220af5e34
ToppCell	nucseq-Immune-Lymphocytic_B-Lymphocytic_B\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NUGGC MYCBP2 BACH2 PLCG2 RUBCN	8.22e-05	184	107	5	942b58ae7172bb5f97e55b032db9329d161854af
ToppCell	Endothelial-E\|World / shred on cell class and cell subclass (v4)	FBLN2 CCM2L MEGF6 MMRN2 NOS3	8.22e-05	184	107	5	b4c561924c508536fd2112e91e32176b95fdf63a
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A VTN MYLK RRAD ZFHX3	8.22e-05	184	107	5	34c84ac9a32eaf96f45b79485119cad65905817d
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A VTN MYLK RRAD ZFHX3	8.43e-05	185	107	5	5f5df92b328be396941b5812d00454b5ff927d30
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	APCDD1 LAMC1 FBLN2 PXDN LRP1	8.43e-05	185	107	5	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A VTN MYLK RRAD ZFHX3	8.43e-05	185	107	5	98547c1b1828b76da810ed86082182afaaacdb3f
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE3A PLSCR5 RRAD PXDN ADAMTS17	8.43e-05	185	107	5	0b5a0df58ae2ad8261f40f152775747af4f3937a
Drug	capsazepine	FOXM1 CACNA1E PLCG2 NOS1 NOS3 ALOX5	2.82e-06	84	107	6	CID002733484
Drug	U46619	CACNA1E PDE3A MYLK CACNA1H PLCG2 NOS1 NOS3 ALOX5 GP5	8.17e-06	285	107	9	CID000005618
Drug	septacidin	NPC1 PLXNA3 FTCD	8.30e-06	9	107	3	CID000096278
Drug	Russian VX	EPHB2 CACNA1E VTN CLTC GP5	1.09e-05	62	107	5	CID000178033
Drug	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	NOS1 NOS3	2.19e-05	2	107	2	DB01821
Drug	S-Ethyl-N-Phenyl-Isothiourea	NOS1 NOS3	2.19e-05	2	107	2	DB03707
Drug	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	NOS1 NOS3	2.19e-05	2	107	2	DB08018
Drug	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	NOS1 NOS3	2.19e-05	2	107	2	DB08019
Drug	AC1NUV1R	VTN GP5	2.19e-05	2	107	2	CID005494399
Drug	tetrakis(4-benzoic acid)porphyrin	NOS3 ALOX5	2.19e-05	2	107	2	ctd:C480958
Drug	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	NOS1 NOS3	2.19e-05	2	107	2	DB02077
Drug	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	NOS1 NOS3	2.19e-05	2	107	2	DB02027
Drug	Nitroarginine	NOS1 NOS3	2.19e-05	2	107	2	DB04223
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	CYLD VLDLR NEK9 RBM5 RNF41 NOTCH2 SORL1	3.37e-05	191	107	7	4168_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; PC3; HT_HG-U133A	EPHB2 CYLD PLXNA3 RIN3 SHMT1 RNF41 PLCG2	3.48e-05	192	107	7	7364_UP
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	BBS9 NEK9 SETD2 MBNL2 RBM5 CACNA1H SORL1	3.72e-05	194	107	7	4727_DN
Drug	Sulfameter [651-06-9]; Down 200; 14.2uM; PC3; HT_HG-U133A	EPHB6 RIN3 MYLK RNF31 ANKRD27 ZFHX3 DBR1	3.72e-05	194	107	7	5732_DN
Drug	Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A	EPHB2 VLDLR REM1 SKI BBS9 MMRN2 RNF41	3.84e-05	195	107	7	3300_UP
Drug	Baclofen (R,S) [1134-47-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A	EPHB2 CYLD TRAPPC11 NEK9 MBNL2 RBM5 CACNA1H	3.97e-05	196	107	7	1536_UP
Drug	Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	CYLD TRAPPC11 REM1 BBS9 NEK9 MBNL2 CACNA1H	4.23e-05	198	107	7	1507_UP
Drug	glutamate	EPHB2 FOXM1 CACNA1E MYLK SHMT1 FTCD CHRNE DHX8 TRIM32 PKLR SCNN1G CACNA1H PLCG2 NOS1 NOS3	4.36e-05	962	107	15	CID000000611
Drug	W-13	MYLK TRIM32 NOS1 NOS3	5.42e-05	44	107	4	CID000004299
Drug	sulfopyruvate	CACNA1E VTN ACOT12 GP5	6.46e-05	46	107	4	CID000440717
Drug	3-Bromo-7-Nitroindazole	NOS1 NOS3	6.54e-05	3	107	2	DB01997
Drug	tyrphostin 47	CACNA1H NOS3	6.54e-05	3	107	2	ctd:C060152
Drug	N-(3-(Aminomethyl)Benzyl)Acetamidine	NOS1 NOS3	6.54e-05	3	107	2	DB02044
Drug	harderoporphyrinogen	CPOX CLTC	6.54e-05	3	107	2	CID000193825
Drug	Heme	NOS1 NOS3 ALOX5	7.82e-05	18	107	3	DB03014
Disease	severe acute respiratory syndrome, COVID-19	EPHB2 RIN3 USP9X BBS9 EYS PXDN MEGF6 NRXN1 MBNL2 ADAMTS17 ZFHX3	5.37e-07	447	104	11	EFO_0000694, MONDO_0100096
Disease	serum IgG glycosylation measurement	CACNA1E BACH2 ZNF407 SKI DHX8 EYS ASAP2 PXDN ADAMTS17 PLCG2	1.65e-05	523	104	10	EFO_0005193
Disease	Intestinal Perforation	NOS1 NOS3	3.68e-05	3	104	2	C0021845
Disease	myotonic disease (implicated_via_orthology)	MBNL1 MBNL2	3.68e-05	3	104	2	DOID:450 (implicated_via_orthology)
Disease	portal hypertension (implicated_via_orthology)	NOS1 NOS3 ALOX5	3.96e-05	19	104	3	DOID:10762 (implicated_via_orthology)
Disease	peak expiratory flow	UTP6 PDE3A APCDD1 EYS ASAP2 ADAMTS17 LRP1 PPP6R3 SORL1	6.88e-05	498	104	9	EFO_0009718
Disease	coronary artery disease	NPC1 MORN1 LAMC1 SKI NEK9 ASAP2 FBN2 NRXN1 LRP1 ZNF727 PLCG2 GPSM1 NOS3 NUP160	7.79e-05	1194	104	14	EFO_0001645
Disease	Obesity	NPC1 VLDLR APCDD1 PHF6 BBS9 ZFHX3	9.01e-05	205	104	6	C0028754
Disease	systemic mastocytosis	CACNA1E EYS MEGF6	9.25e-05	25	104	3	MONDO_0016586
Disease	Alzheimer's disease (is_implicated_in)	VLDLR LRP1 NOS1 NOS3 SORL1	1.07e-04	132	104	5	DOID:10652 (is_implicated_in)
Disease	Insulinogenic index measurement	MYCBP2 GPSM1	1.22e-04	5	104	2	EFO_0009961
Disease	irritable bowel syndrome (implicated_via_orthology)	EPHB2 NOS3	1.22e-04	5	104	2	DOID:9778 (implicated_via_orthology)
Disease	myotonic dystrophy type 2 (implicated_via_orthology)	MBNL1 MBNL2	1.22e-04	5	104	2	DOID:0050759 (implicated_via_orthology)
Disease	myotonic dystrophy type 1 (implicated_via_orthology)	MBNL1 MBNL2	1.83e-04	6	104	2	DOID:11722 (implicated_via_orthology)
Disease	retinal degeneration (implicated_via_orthology)	EYS NOS3 VDAC2	2.15e-04	33	104	3	DOID:8466 (implicated_via_orthology)
Disease	asthma (is_implicated_in)	MYLK CHML NOS1 NOS3 ALOX5	2.41e-04	157	104	5	DOID:2841 (is_implicated_in)
Disease	brain ischemia (implicated_via_orthology)	NOS1 NOS3 ALOX5	2.56e-04	35	104	3	DOID:2316 (implicated_via_orthology)
Disease	poly(A) RNA polymerase, mitochondrial measurement	VTN MTPAP	3.40e-04	8	104	2	EFO_0801893
Disease	N-acetylneuraminate measurement	LAMC1 ASAP2	3.40e-04	8	104	2	EFO_0020022
Disease	pulse pressure measurement	NPC1 RIN3 PDE3A MBNL1 RABGAP1 ANKRD36C INTS8 NEK9 DHX8 ASAP2 FBN2 LRP1 ZFHX3 NUP160	3.79e-04	1392	104	14	EFO_0005763
Disease	myeloid white cell count	NPC1 VLDLR RIN3 PDE3A BACH2 MBNL1 SETD2 ZFHX3 NUP160 NOTCH2 SORL1	4.74e-04	937	104	11	EFO_0007988
Disease	Diabetes, Autoimmune	BACH2 NOS1 NOS3	5.07e-04	44	104	3	C0205734
Disease	Brittle diabetes	BACH2 NOS1 NOS3	5.07e-04	44	104	3	C0342302
Disease	Diabetes Mellitus, Sudden-Onset	BACH2 NOS1 NOS3	5.07e-04	44	104	3	C4554117
Disease	Diabetes Mellitus, Ketosis-Prone	BACH2 NOS1 NOS3	5.07e-04	44	104	3	C3837958
Disease	Diabetes Mellitus, Insulin-Dependent	BACH2 NOS1 NOS3	5.42e-04	45	104	3	C0011854
Disease	diabetic retinopathy (biomarker_via_orthology)	VTN NOS1 NOS3	5.42e-04	45	104	3	DOID:8947 (biomarker_via_orthology)
Disease	HMG CoA reductase inhibitor use measurement	MORN1 DHRS11 SKI SETD2 NOS3	5.63e-04	189	104	5	EFO_0009932
Disease	Familial thoracic aortic aneurysm and aortic dissection	MYLK SKI FBN2	8.77e-04	53	104	3	C4707243
Disease	cardiomyopathy (biomarker_via_orthology)	NOS1 NOS3	9.36e-04	13	104	2	DOID:0050700 (biomarker_via_orthology)
Disease	Bardet-Biedl syndrome (is_implicated_in)	BBS9 TRIM32	1.09e-03	14	104	2	DOID:1935 (is_implicated_in)
Disease	Autosomal recessive limb-girdle muscular dystrophy	TRAPPC11 TRIM32	1.09e-03	14	104	2	cv:C2931907
Disease	Atherosclerosis	NPC1 NOS3 ALOX5	1.20e-03	59	104	3	C0004153
Disease	Atherogenesis	NPC1 NOS3 ALOX5	1.20e-03	59	104	3	C1563937
Disease	myocardial infarction	MORN1 LAMC1 SKI PLCG2 GPSM1 NOS3	1.53e-03	350	104	6	EFO_0000612
Disease	Bardet-Biedl syndrome 1 (disorder)	BBS9 TRIM32	1.62e-03	17	104	2	C2936862
Disease	Bardet-Biedl syndrome	BBS9 TRIM32	1.81e-03	18	104	2	cv:C0752166
Disease	Alzheimer disease, educational attainment	NPC1 LAMC1 NRXN1 RBM5 SORL1	1.85e-03	247	104	5	EFO_0011015, MONDO_0004975
Disease	colorectal cancer, colorectal adenoma	LAMC1 LRP1 TTC22 NOS1	2.09e-03	152	104	4	EFO_0005406, MONDO_0005575
Disease	Paroxysmal atrial fibrillation	LHX3 ZFHX3 NOS3 SORL1	2.29e-03	156	104	4	C0235480
Disease	familial atrial fibrillation	LHX3 ZFHX3 NOS3 SORL1	2.29e-03	156	104	4	C3468561
Disease	Persistent atrial fibrillation	LHX3 ZFHX3 NOS3 SORL1	2.29e-03	156	104	4	C2585653
Disease	bone density, lean body mass	RIN3 PPP6R3	2.47e-03	21	104	2	EFO_0003923, EFO_0004995
Disease	hemoglobin A1 measurement	PDE3A MBNL1 SKI ANKRD27 SETD2 GPSM1 NOTCH2	2.48e-03	520	104	7	EFO_0007629
Disease	Atrial Fibrillation	LHX3 ZFHX3 NOS3 SORL1	2.51e-03	160	104	4	C0004238
Disease	epilepsy (implicated_via_orthology)	CACNA1E LRP1 NOS1 NOS3	2.69e-03	163	104	4	DOID:1826 (implicated_via_orthology)
Disease	impotence (biomarker_via_orthology)	NOS1 NOS3	2.71e-03	22	104	2	DOID:1875 (biomarker_via_orthology)
Disease	pulmonary hypertension (biomarker_via_orthology)	PDE3A NOS3 ALOX5	2.87e-03	80	104	3	DOID:6432 (biomarker_via_orthology)
Disease	QT interval	PDE3A LAMC1 PXDN ZFHX3 NUP160 CDC23 PPP6R3	2.87e-03	534	104	7	EFO_0004682
Disease	chronic widespread pain	ASAP2 PLCG2	2.97e-03	23	104	2	EFO_0010099
Disease	temperament and character inventory	FBN2 NRXN1	3.23e-03	24	104	2	EFO_0004825
Disease	nephrotic syndrome (biomarker_via_orthology)	VLDLR NOS1	3.23e-03	24	104	2	DOID:1184 (biomarker_via_orthology)
Disease	Allodynia	CACNA1H NOS1 ALOX5	3.30e-03	84	104	3	C0458247
Disease	Mechanical Allodynia	CACNA1H NOS1 ALOX5	3.30e-03	84	104	3	C2936719
Disease	Hyperalgesia, Secondary	CACNA1H NOS1 ALOX5	3.30e-03	84	104	3	C0751212
Disease	Hyperalgesia, Primary	CACNA1H NOS1 ALOX5	3.30e-03	84	104	3	C0751211
Disease	Hyperalgesia, Thermal	CACNA1H NOS1 ALOX5	3.30e-03	84	104	3	C0751214
Disease	Tactile Allodynia	CACNA1H NOS1 ALOX5	3.30e-03	84	104	3	C0751213
Disease	Hyperalgesia	CACNA1H NOS1 ALOX5	3.30e-03	84	104	3	C0020429
Disease	Leukemia, Myelocytic, Acute	BACH2 SETD2 PXDN NOTCH2	3.33e-03	173	104	4	C0023467
Disease	Colorectal Carcinoma	EPHB6 LAMC1 FBLN2 FBN2 LRP1 SCNN1G MMRN2 SORL1	3.43e-03	702	104	8	C0009402

Protein segments in the cluster

Peptide	Gene	Start	Entry
SEDGLFVCRKDAACQ	BACH2	136	Q9BYV9
CCAFNDTREEGKALL	CDC23	536	Q9UJX2
CGVEADKELSCRQQA	CCNT2	26	O60583
CEREACANILIDAGA	ANKRD30B	116	Q9BXX2
ECSLEKNERACIDFA	CACNA1E	1436	Q15878
QTCVEVGVRVEAFDC	ACOT12	256	Q8WYK0
RVLTADFCAGCKVND	ADCK5	311	Q3MIX3
DFCAGCKVNDVEAIR	ADCK5	316	Q3MIX3
CTELRDKIACNGDAS	ATAD2	1261	Q6PL18
RDAAEESCALICQVF	CCM2L	311	Q9NUG4
VCSAKRKCVLAEDNG	ADAMTS17	366	Q8TE56
AAPEVRCCVDAVNFV	CHRNE	416	Q04844
VQCFVVDKESGRCKA	CHML	406	P26374
RDQCLAVCDGVLGVF	ERAS	106	Q7Z444
TIDEKRLAGYCQACD	INTS8	296	Q75QN2
DEGRACAVVFDCKFI	RRAD	216	P55042
RDQELAFQGTVDKCC	ANKRD36C	1486	Q5JPF3
FCDDCEKLVSGRLND	ANKRD27	436	Q96NW4
ACQRVEQGCAEFTDV	MORN1	356	Q5T089
VDDCERCREFFNKEG	RABGAP1	966	Q9Y3P9
ADKARDGVCDEACNS	NOTCH2	1431	Q04721
KDCAVIEGQDFVLQC	MYLK	521	Q15746
LAEDGKRCVAVDYCA	MATN2	311	O00339
DANQHCICREEFEGK	EYS	871	Q5T1H1
KAIRQVSCGDDFTVC	NEK9	426	Q8TD19
LKVLGRFDEAAVCCQ	GPSM1	116	Q86YR5
NDVKNVGRCCEAEAG	MMRN2	706	Q9H8L6
ICGDEARCVRTEKAA	LRP1	3791	Q07954
TQALEKFGGNCVCRD	ASAP2	76	O43150
LNADEAVARGCALQC	HSPH1	366	Q92598
CKAGFEAVENGTVCR	EPHB2	256	P29323
ADGKRCEDVNECEAQ	FBLN2	936	P98095
CGCFGDVDFEVKTIN	PLSCR5	196	A0PG75
VELCVGDCSADFRTQ	PLXNA3	911	P51805
VRGEVGCDLEQCKEA	PDE3A	81	Q14432
ECFNKISRDADCRAV	ECH1	91	Q13011
AIGAVEAAFKCCAAA	PKLR	456	P30613
FACVVCKRQLATGDE	LHX3	116	Q9UBR4
CDILEAANKRGVFVC	FAM83A	176	Q86UY5
DFERAKAVRQKEDCC	PLCG2	81	P16885
VVDDQAVCDCSRTGF	NRXN1	236	Q9ULB1
ADAEDKCVIEGNNCT	MTPAP	406	Q9NVV4
CFRCGADKFDSEQEV	RBM5	201	P52756
DKEEFDQGCLCLANV	BBS9	16	Q3SYG4
KAACDVFCVGDDVNI	NOS1	941	P29475
ACETFCVGEDAKAAA	NOS3	706	P29474
EVEDAVQKVCNATGC	OTUD3	231	Q5T2D3
EKNRLDIFCCVRGAE	NPC1	791	O15118
CRKEIQGFLDCAARA	CHCHD1	66	Q96BP2
EDELCFLRANECKTG	DPP9	436	Q86TI2
GRTVALCENDCDDKA	DIS3L	306	Q8TF46
EGCIAAENCIGIRDF	GAN	126	Q9H2C0
REENGCECTKAVNFA	APCDD1	191	Q8J025
KSCQVENGRVIACFD	MBNL1	41	Q9NR56
KSCQVENGRVIACFD	MBNL2	41	Q5VZF2
TDKLEVCREFQRGNC	MBNL2	176	Q5VZF2
EQKRETCADGEAAGC	FOXM1	161	Q08050
KCVFRDAAQCSGGDV	GP5	26	P40197
GRCVCKDNVEGFNCE	LAMC1	461	P11047
CCGDFQAVRNEADLR	DBR1	36	Q9UK59
ARIKGVTCEDVNECE	FBN2	946	P35556
LFQCDEDCGVFVALD	CYLD	186	Q9NQC7
VECGSERCNILEAFD	CACNA1H	126	O95180
CARTVGNIEELAAEC	DHRS11	41	Q6UWP2
AVCIADREEKGCTSQ	DHX40	31	Q8IX18
AKGFICEFCQNEDDI	RUBCN	886	Q92622
IACDNAVFGCSAVVR	RNF41	81	Q9H4P4
AFVQEELGCQSVCKE	SCNN1G	441	P51170
SCVLQDGCVFEKAGV	CPOX	191	P36551
LAGQIARACAIFCVD	SPOUT1	96	Q5T280
VAKRVSEEFGCCLGQ	DHX8	626	Q14562
VDECVLCAQAFGQRL	FTCD	101	O95954
CICDLARSIDFNKDG	PPEF2	696	O14830
CGDLVSCFQERARIE	PACSIN3	36	Q9UKS6
SVEEGRACAVVFDCK	REM1	206	O75628
CAQCAEKFAVERPQA	RIN3	906	Q8TB24
GRAEKVLEACSIACN	SHMT1	371	P34896
KACEDVDECAAGLAQ	MEGF6	281	O75095
CVLDGDKDSVNCARQ	USP9X	831	Q93008
QAKAVEVGRKEERCC	UTP6	296	Q9NYH9
SREFQCEDGEACIVL	SORL1	1516	Q92673
ESIKACQRGFCRDVA	NUGGC	336	Q68CJ6
ENEDFRCIAGMCVDA	TRIM32	571	Q13049
AREQLICECGLFDKA	ALOX5	411	P09917
LLFNVVCKECEGRQE	EPHB6	401	O15197
KDQVFGCALAALCER	ARHGAP27	691	Q6ZUM4
VGVESACDVDCRFKL	SIN3B	1046	O75182
CKACARELDGQEARQ	MYCBP2	811	O75592
CANCGKELTADAREL	LIMS1	161	P48059
ALECFCQAASEVGKE	NUP160	926	Q12769
LEQARQARVCDKGCE	SKI	641	P12755
VCFACVDGKEFRLAQ	CLTC	1256	Q00610
GIKRDFATVCQECTD	C12orf4	341	Q9NQ89
FENEAAAVLCSICER	RNF31	361	Q96EP0
EECGKDCRLSDFTIQ	ZNF727	176	A8MUV8
KCGFCHVGEEENEAR	PHF6	211	Q8IWS0
ERAAALCNACELSGK	TRAPPC11	156	Q7Z392
LNADEAVARGCALQC	HSPA4L	366	O95757
ICECKDGQVTCFVEA	PXDN	1436	Q92626
ELDFACDQCGRRFEK	ZNF276	551	Q8N554
RECINLGCDVDFDFA	VDAC2	131	P45880
KDERAQGEIACGEDC	SETD2	1506	Q9BYW2
GNIERECKEEFCTFE	PRRG1	31	O14668
FEECIERVCIGANDK	ZNF407	771	Q9C0G0
GNIALFEACCKERIQ	PPP6R3	596	Q5H9R7
FEACCKERIQQFDDG	PPP6R3	601	Q5H9R7
CLRIKGEDANAAACF	TTC22	441	Q5TAA0
GEDANAAACFKRAVE	TTC22	446	Q5TAA0
VALADQESCKGRCTE	VTN	16	P04004
VCRKCQAGFSDEEAA	ZFHX3	3466	Q15911
EQKGDCAAALALCNE	USP54	811	Q70EL1
RDCVDGSDEVNCKNV	VLDLR	301	P98155